Endometrial mixed mullerian tumor with heterologous elements following tamoxifen therapy for breast cancer: a case report and literature review

By Kaleli S.   Calay Z.   Altinok T.   Kosebay D.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 101, Iss. 2, 2002-03 ,pp. : 204-208

Elsevier

Access to resources Recommend Favorite

Endometrial and other primary cancers after tamoxifen treatment of breast cancer - results of retrospective cohort study

By Ursic Vrscaj M.   Kovacic J.   Bebar S.   Djurisic A.   Fras P.-A.   Robic V.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 95, Iss. 1, 2001-03 ,pp. : 105-110

Elsevier

Access to resources Recommend Favorite

Clinical effects of tibolone in postmenopausal women after 5 years of tamoxifen therapy for breast cancer

By Dimitrakakis C.   Keramopoulos D.   Vourli G.   Gaki V.   Bredakis N.   Keramopoulos A.  

Climacteric, Vol. 8, Iss. 4, 2005-12 ,pp. : 342-351

Informa Healthcare

Access to resources Recommend Favorite

Endometrial polyp secondary to tamoxifen therapy

By Ansbacher R.   Advincula A.P.  

Fertility and Sterility, Vol. 80, Iss. 1, 2003-07 ,pp. : 216-217

Elsevier

Access to resources Recommend Favorite

A case of concurrent endometrial carcinoma, fallopian tube carcinoma and a benign right ovarian serous cystadenoma with tamoxifen therapy

By Soltan A. S.   Hutcheson R. B.  

Journal of Obstetrics & Gynaecology, Vol. 17, Iss. 6, 1997-12 ,pp. : 596-596

Informa Healthcare

Access to resources Recommend Favorite